Dysregulation of epigenetic, biological and mitotic age in the context of biologic drug treatment and phototherapy in plaque psoriasis patients
Richie Jeremian(McGill University Health Centre), Vincent Piguet(University of Toronto), Melinda Gooderham(Queen's University), Muskaan Sachdeva(University of Toronto), David Croitoru(University of Toronto), Jensen Yeung(Sunnybrook Health Science Centre), Yuliya Lytvyn(University Health Network), Rayyan Fotovati(McGill University Health Centre), Alexandra Malinowski, Kaiyang Li(McGill University Health Centre), Carolyn Jack(McGill University Health Centre)
Cited by 2
Related Papers
Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways
|Proceedings of the National Academy of Sciences|2007|531
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis
|JAMA Dermatology|2019|516
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
|Circulation|2017|470
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial
|Journal of the American Academy of Dermatology|2020|396